The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake

March 14, 2023 updated by: Bohdan Luhovyy, Mount Saint Vincent University

The Effect of Food Formulated With Pulse Flours on Blood Glucose, Satiety and Food Intake

Pulse flours represent a fast-growing segment on the functional food market; however, their health effects are not well understood. The observational studies and acute trials have established the link between frequent consumption of cooked whole pulses (beans, peas, lentils and chickpeas) and healthier body weight and improved blood glucose control. However, it is not clear whether these effects still remain after the processing of pulses into flours. The investigators hypothesized that the baked food products formulated with lentil flour of the same particle size as all-purpose wheat flour may reduce postprandial glycaemia and elicit a stronger suppression of subjective appetite due to its higher content of protein and resistant carbohydrate compared to all-purpose wheat flour. The treatments will be formulated either with lentil flour or with all-purpose wheat flour of similar particle size or with their combination. The objective of the project is to test the effect of foods formulated with lentil flour and/or wheat flour on blood glucose, short-term food intake and subjective appetite.

Study Overview

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3M 2J6
        • Mount Saint Vincent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy young male and female adults (19-35 y) with body mass index (BMI) of 20.0-24.9kg/m2

Exclusion Criteria:

  • Breakfast skippers
  • Smokers (including e-cigarettes) / cannabis consumers
  • Those with BMI < 18.5 and > 24.5 kg/m2
  • People with chronic diseases
  • People with impaired blood glucose control
  • People taking medication that may affect central and peripheral mechanisms of food intake regulation, blood glucose control, cognitive performance and sedative medication.
  • People with intellectual disabilities (excluded due to their inability to comprehend hedonic and visual analogue scales used in the study).
  • People with food allergies or gastrointestinal disorders (e.g., IBS and others).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Baked food made of lentil flour
Food prepared with 100% lentil flour
Baked food made of lentil flour
Experimental: Baked food made of lentil flour and wheat flour
Food prepared with a mixture of lentil flour and wheat flour
Baked food made of lentil flour and wheat flour
Experimental: Baked food made of wheat flour
Food prepared with 100% wheat flour
Baked food made of wheat flour
Experimental: Water
Potable water (energy and carbohydrate-free control)
Potable water (energy and carbohydrate-free control)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Glucose
Time Frame: 0-120 minutes
The concentration of venous blood glucose before and after each treatment consumption
0-120 minutes
Food Intake
Time Frame: 120 minutes
The amount of energy (kcal) consumed ad libitum at the test meal (pizza lunch) two hours after each treatment consumption
120 minutes
Subjective Appetite
Time Frame: 0-120 minutes
The subjective assessment of appetite parameters including desire to eat, fullness, hunger and a prospective food consumption measured with 100 mm Visual Analogue Scales with two opposite statements at each end (e.g., for the hunger scale, 0 mm means not hungry at all, and 100 mm means very hungry).
0-120 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Comfort
Time Frame: 0-120 minutes
The subjective assessment of wellness and gastrointestinal symptoms including a feeling of nausea, diarrhea, flatulence, and other parameters measured with 100 mm Visual Analogue Scales with two opposite statements at each end.
0-120 minutes
Palatability of Food
Time Frame: 5 minutes
The palatability of the treatments will be measured immediately after consumption with a 100 mm Visual Analogue Scale with two opposite statements at each end or with a 9-point hedonic scale.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bohdan Luhovyy, PhD, Mount Saint Vincent University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2019

Primary Completion (Actual)

August 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

May 2, 2020

First Submitted That Met QC Criteria

May 5, 2020

First Posted (Actual)

May 7, 2020

Study Record Updates

Last Update Posted (Actual)

March 16, 2023

Last Update Submitted That Met QC Criteria

March 14, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-201

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Glucose

Clinical Trials on Food-1

3
Subscribe